XSHE
300637
Market cap396mUSD
Dec 05, Last price
11.95CNY
1D
1.53%
1Q
-13.03%
IPO
49.27%
Name
Zhejiang Yangfan New Materials Co Ltd
Chart & Performance
P/E
—
P/S
3.84
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.44%
Rev. gr., 5y
7.41%
Revenues
731m
+5.80%
Net income
-46m
L-47.52%
CFO
32m
+41.85%
Dividend
Jun 22, 20210.03 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Yangfan New Materials Co., Ltd. researches, develops, produces, and sells ultraviolet (UV) curing products, sulfur-containing fine chemicals, and related new materials worldwide. The company offers thiophenol, diphenyl sulfide, diphenyl disulfide, cyprosulfonamide, thioacetamide, and photoinitiator; and intermediates, including phenyl sulfide, thioanisole, thiophene, thiophenol, pyridine and aniline, sulfone and sulfoxide, and other intermediates. Its photointiator products are used in UV coatings, UV inks, and resistant for printed circuit boards; and sulfur-containing fine chemicals are used in pharmaceuticals, pesticides, electronic chemicals, etc. Zhejiang Yangfan New Materials Co., Ltd. was founded in 2002 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||